# Ranolazine SR in Patients With Chronic Angina Who Remain Symptomatic Despite Maximal Treatment With Amlodipine

> **NCT00091429** · PHASE3 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 500 (—)

## Conditions studied

- Angina

## Interventions

- **DRUG:** Ranolazine

## Key facts

- **NCT ID:** NCT00091429
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2005-02
- **Final completion:** 2005-02
- **Target enrollment:** 500 (—)
- **Last updated:** 2009-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00091429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00091429, "Ranolazine SR in Patients With Chronic Angina Who Remain Symptomatic Despite Maximal Treatment With Amlodipine". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00091429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*